In the mammary fat pad prevention model, vaccination twice with 105 IU VRP-neu or vaccination three times with 104 IU VRP-neu completely prevented tumor growth in many mice and significantly reduced the tumor mass in the entire group compared with the tumor mass of the mice vaccinated three times with VRP-HA (Fig. 3a). Here, ERBB2 is linked to neoplasm.